FuturHealth logo

FuturHealth Review

6.8
★★★☆☆3.4/5

GLP-1 weight-loss telehealth · Independently scored 6.8/10

Best for: brand-name and compounded GLP-1s with registered-dietitian coaching

FuturHealth scores highest on the strength of its clinical program: drug options and dosing support.

What the plan covers

Medication

Included

Provider visits

Not stated

Shipping

Not stated

Lab work

Not stated

Coaching

Included

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

FuturHealth Inc. is a San Diego-based telehealth weight management brand offering brand-name Ozempic, Wegovy (injection AND oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron oral pill, added Q2 2026) plus clinician-discretionary compounded GLP-1/GIP combinations, dispensed through US-based licensed pharmacies. The platform layers digital coaching and registered-dietitian nutrition guidance on top of the medication.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
CompoundedBrandOral OptionOrforglipronWegovyOzempicZepboundMounjaro

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money

Vetted alternatives to FuturHealth

7.7/ 10
Partner

Ro

Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help

★★★★☆3.9/5

Editorial score · methodology

$149/mosemaglutide
+ required membership
BrandSemaglutideTirzepatideOrforglipron
Get StartedRead full Ro review →
8.3/ 10
Partner

Collective

Best for: the lowest flat medication price if you can absorb an annual membership fee

★★★★☆4.2/5

Editorial score · methodology

$59/mosemaglutide
+ required membership
$69/motirzepatide
+ required membership
CompoundedSemaglutideTirzepatide
Get StartedRead full Collective review →
8.3/ 10
Partner

CoreAge Rx

Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose

★★★★☆4.2/5

Editorial score · methodology

$79/mosemaglutide
starting price
$129/motirzepatide
starting price
CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified
Get StartedRead full CoreAge Rx review →
FuturHealth logo
3.4 / 5
Our editorial rating
Visit FuturHealth →

FuturHealth at a glance

Type
GLP-1 telehealth provider
Medications
Orforglipron, Wegovy, Ozempic, Zepbound, Mounjaro
What's included
Medication · Coaching
FDA status
No FDA warning letter on record

How we scored FuturHealth

Each dimension is scored algorithmically from FuturHealth'spublished pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.

Value25%

6.0/10

FuturHealth does not post a standard monthly cash price up front, so cost transparency is limited. Confirm the ongoing rate before you commit.

Effectiveness25%

7.8/10

FuturHealth offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.9/10

Online intake and platform experience; 8 platform features disclosed.

Trust & Safety15%

7.0/10

Core details confirmed by our editors; no FDA warning letters on file.

Accessibility10%

5.8/10

FuturHealth's exact state footprint isn't published. Confirm coverage in your state before signing up.

Support10%

6.9/10

Coaching/dietitian access included.

6scored dimensions
679providers compared

Each checked against the provider’s own site.

Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this FuturHealth review

Last checked November 2026
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the provider's public sign-up flow, stopping before payment

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.

What we checked

FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with FuturHealth

We walked FuturHealth's public signup flow in July 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1'See if you qualify' via the funnel quiz.
  2. 2The program 'includes access to weight-loss medication' plus personalized nutrition plans.
Price shown only after intake
  • The homepage shows intro-month prices only ('Intro month as low as $198 /mo' for Foundayo and Wegovy pill, $299 Wegovy pen, $395 Zepbound); the entry point is a qualification quiz.
  • Landing page names Wegovy, Ozempic, Zepbound, Mounjaro, and its own Foundayo pill.
  • Detailed pricing and steps appear inside the quiz.
  • Phone labeled 'speak with an onboarding specialist,' plus online chat.

FuturHealth customer support

GLP-1 medications FuturHealth offers

Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.

What we like

  • LegitScript Certified and HITRUST Certified
  • Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
  • Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
  • Bundled registered-dietitian nutrition guidance, which is uncommon among pure-Rx telehealths

Watch-outs

  • Active lawsuit (Wilson vs. FuturHealth) alleging unauthorized access to G-Plans subscriber data
  • BBB complaints describe recurring charges without medication received, so confirm the cancellation flow first
  • Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
  • Only intro-month prices show up front (from $198 Foundayo or Wegovy pill, $299 Wegovy pen, $395 Zepbound); ongoing prices follow the quiz
  • Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber

FuturHealth: a brand-name-and-pill GLP-1 shop with a dietitian bolted on

FuturHealth is one of the few telehealth weight-loss brands that puts almost the entire GLP-1 menu on a single platform: brand-name Wegovy (both the injection and the newer oral pill), Ozempic, Mounjaro, and Zepbound, plus compounded semaglutide and clinician-discretionary compounded GLP-1/GIP blends. It was also early to add Foundayo, Eli Lilly's orforglipron pill that the FDA approved in April 2026. If your main goal is choice (and especially if you want a needle-free option), FuturHealth delivers more shelf than most. But you can't see what any of it costs until you've finished a quiz, and the company faces an open data-privacy lawsuit and a pattern of billing complaints.

How the pricing works (and why you won't see it up front)

FuturHealth runs a membership model that bundles the medication, a digital weight-loss platform, ongoing clinician guidance, and a dietitian-built meal program. What it does not do is tell you what any of that costs. Across the landing page, the products-and-services page and the how-it-works page there is not a single dollar amount, and even the /pricing address just serves the homepage again. Every figure (compounded, brand-name and Foundayo alike) appears only after you answer the qualification questionnaire or log into the portal. The page does flag the program as FSA and HSA eligible, which can soften the cost if you have those funds.

Practically, that means you should treat any number you've seen quoted elsewhere as unconfirmed until FuturHealth shows it to you in your own checkout. Read the recurring-billing terms on that screen carefully before you hand over a card, because repeat-charge complaints are among its drawbacks.

The medications and how they're dispensed

This is FuturHealth's strongest card. On one account you can potentially get:

  • Brand-name Wegovy as an injection or as the oral pill
  • Brand-name Ozempic, Mounjaro, and Zepbound
  • Foundayo (orforglipron), the new once-daily oral, non-peptide GLP-1
  • Compounded semaglutide and clinician-discretionary compounded GLP-1/GIP (tirzepatide) combinations

Everything is shipped through what FuturHealth describes only as 'licensed, U.S.-based pharmacies.' The company doesn't publicly name its 503A or 503B partners the way some competitors do, so you're trusting the brand rather than a specific, accreditation-listed pharmacy.

Pill access plus a dietitian layer

Two things make FuturHealth distinct from the pack of pure-prescription telehealths. First is needle-free breadth: between Wegovy's oral pill and early Foundayo access, this is one of the easier places to start an oral GLP-1 if injections are a dealbreaker for you. Second is the nutrition layer: the membership includes a GLP-1-tailored meal program designed by registered dietitians, and FuturHealth even folds in Apple Fitness+ access. Bundled RD guidance is uncommon among telehealths that mostly just mail you a vial, and for people who want the food-and-habit side handled alongside the drug, that's a legitimate reason to pick FuturHealth over a bare-bones script mill.

Who runs the clinical side

FuturHealth Inc. is a San Diego company, and on paper it carries the credentials you'd want: it's LegitScript Certified and HITRUST Certified, which speak to legitimate-pharmacy and data-security standards respectively. Under the hood, though, the prescribing and clinician infrastructure is white-labeled on SteadyMD and OpenLoop rather than a first-party medical group. That's a common arrangement in this space and not disqualifying, though it does mean the 'FuturHealth doctor' you interact with is operating through third-party clinical rails.

The drawbacks you should weigh before signing up

Four concrete problems hold FuturHealth's score down:

  • There's active litigation: Wilson v. FuturHealth Inc. (S.D. Cal.) alleges unauthorized access to G-Plans subscriber data. It's unresolved, and it concerns data privacy, which matters a lot for a health platform.
  • There's a recurring pattern of Better Business Bureau complaints describing repeat charges without medication received. Confirm exactly how to cancel, and screenshot it, before your first payment.
  • Pricing is hidden behind the quiz, so you can't comparison-shop without surrendering your information first.
  • Pharmacy partners aren't named, so you can't independently vet who's compounding or shipping your medication.

Who should choose FuturHealth, and who should skip it

Choose it if you specifically want oral GLP-1 options (Wegovy pill or Foundayo), if you value a built-in dietitian and meal plan rather than just a prescription, and if you're comfortable doing your own diligence on the billing terms. Skip it if you're price-sensitive and want a number before you commit, if the open data-privacy lawsuit makes you uneasy about handing over health information, or if you'd rather use a provider that names its pharmacy and runs its own clinicians. If billing transparency is your top priority, you'll likely be happier elsewhere; compare on our scoring methodology before deciding.

Bottom line

FuturHealth has one of the widest medication menus in GLP-1 telehealth (brand-name, compounded, injectable, and pill all in one place), plus a dietitian layer most rivals don't bother with. But the hidden pricing, the unresolved data-breach litigation, and the cluster of unauthorized-charge complaints weigh just as heavily, and they're why we don't rank it among our top picks. It's a defensible choice for the right shopper who reads the fine print carefully; it's not a set-and-forget pick. Go in with your eyes open, confirm the cancellation flow first, and check every price inside your own account.

The Bottom Line

FuturHealth scores highest on the strength of its clinical program: drug options and dosing support.

Score: 6.8/10Best for: brand-name and compounded GLP-1s with registered-dietitian coaching

Ready to start with FuturHealth?

See current pricing and start your online intake.

Frequently Asked Questions

FuturHealth is a telehealth weight-management platform where you complete an online questionnaire, a licensed clinician reviews it, and eligible patients receive medication through US-based licensed pharmacies. It layers digital coaching and registered-dietitian nutrition guidance on top of the medication.
It offers brand-name Ozempic, Wegovy (both injection and oral pill), Mounjaro, Zepbound, and Foundayo (orforglipron), plus clinician-discretionary compounded GLP-1/GIP options. A licensed clinician determines which, if any, is appropriate for you.
FuturHealth does not display pricing publicly; costs are shown after you complete the qualification questionnaire or log in. The program is marketed as FSA/HSA eligible, and the medication is included with the subscription.
FuturHealth is LegitScript Certified and HITRUST Certified. Buyers should also be aware of an active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data, and BBB complaints describing recurring charges, so confirm the cancellation flow before enrolling.
Yes. Per FuturHealth's FAQ, it offers select GLP-1/GIP medications in pill form for those who prefer not to inject, including Wegovy's oral pill and Foundayo. Suitability for any oral option is decided by the prescribing clinician.
You complete FuturHealth's qualification questionnaire, and a clinician reviews your intake before any prescription is issued. Because billing complaints exist for this platform, review the subscription and cancellation terms carefully first.
FuturHealth doesn't use public promo or coupon codes. Third-party sites advertising "FuturHealth discount codes" are typically fake; any current offer applies automatically through the link on this page.
We don't collect customer complaints, so this covers what our own review found. There is no FDA warning letter on file for FuturHealth. The concerns our review flags: Active lawsuit (Wilson vs. FuturHealth) alleging unauthorized access to G-Plans subscriber data; BBB complaints describe recurring charges without medication received, so confirm the cancellation flow first; pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names; only intro-month prices show up front (from $198 Foundayo or Wegovy pill, $299 Wegovy pen, $395 Zepbound); ongoing prices follow the quiz. Weigh them before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this FuturHealth review:

Sources & methodology (as of November 2026)
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  4. 4.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.

See FuturHealth's current pricing

Start the online intake to check eligibility and today's price.